FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

38030111000001100: Rinvoq 15mg modified-release tablets (AbbVie Ltd) (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 19-Feb 2020. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    1152261000001110 Rinvoq 15mg modified-release tablets (AbbVie Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
    1152271000001117 Rinvoq 15mg modified-release tablets (AbbVie Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Rinvoq 15mg modified-release tablets (AbbVie Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none false Inferred relationship Existential restriction modifier
    Rinvoq 15mg modified-release tablets (AbbVie Ltd) Is a Upadacitinib hemihydrate 15mg tablets false Inferred relationship Existential restriction modifier
    Rinvoq 15mg modified-release tablets (AbbVie Ltd) Is a Actual medicinal product false Inferred relationship Existential restriction modifier
    Rinvoq 15mg modified-release tablets (AbbVie Ltd) Has excipient Excipient not declared false Inferred relationship Existential restriction modifier
    Rinvoq 15mg modified-release tablets (AbbVie Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring false Inferred relationship Existential restriction modifier
    Rinvoq 15mg modified-release tablets (AbbVie Ltd) Is a Rinvoq false Inferred relationship Existential restriction modifier
    Rinvoq 15mg modified-release tablets (AbbVie Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
    Rinvoq 15mg modified-release tablets (AbbVie Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Upadacitinib false Inferred relationship Existential restriction modifier
    Rinvoq 15mg modified-release tablets (AbbVie Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
    Rinvoq 15mg modified-release tablets (AbbVie Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status false Inferred relationship Existential restriction modifier
    Rinvoq 15mg modified-release tablets (AbbVie Ltd) Has specific active ingredient Upadacitinib hemihydrate false Inferred relationship Existential restriction modifier
    Rinvoq 15mg modified-release tablets (AbbVie Ltd) Has dispensed dose form Modified-release oral tablet false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Rinvoq 15mg modified-release tablets (AbbVie Ltd) 28 tablet 4 x 7 tablets Has AMP False Rinvoq 15mg modified-release tablets (AbbVie Ltd) Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start